Flubendazole
-
Flubendazole
structure -
-
CAS No:
31430-15-6
-
Formula:
C16H12FN3O3
-
Chemical Name:
Flubendazole
-
Synonyms:
Carbamic acid,N-[6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]-,methyl ester;2-Benzimidazolecarbamic acid,5-(p-fluorobenzoyl)-,methyl ester;Carbamic acid,[5-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]-,methyl ester;Flubendazole;R 17899;Methyl (5-p-fluorobenzoyl-2-benzimidazolyl)carbamate;Flubenol;Fluvermal;R 17889;Flumoxane;Flumoxal;NSC 313680;Flubenvet
- Categories:
-
CAS No:
Description
White Solid
Flubendazole is a member of the class of mebendazole in which the benzoyl group is replaced by a p-fluorobenzoyl group. A broad-spectrum anthelmintic, it is used, particularly in veterinary medicine, for the treatment of nematodal infections. It has a role as an antinematodal drug and a teratogenic agent. It is a member of benzimidazoles, a carbamate ester, an organofluorine compound and an aromatic ketone.|Flubendazole is an anthelmintic that is used to treat worm infection in humans. It is available OTC in Europe.
Flubendazole Basic Attributes
313.28
313.28
250-624-4
R8M46911LR
313680
DTXSID8023058
P - Antiparasitic products, insecticides and repellents
29339900
Characteristics
84.1
2.9
white to pale yellow powder
1.3720 (estimate)
260 °C
1.685
LD50 in mice, rats, guinea pigs (mg/kg): >2560 orally (Thienpont)
177.36 Ų [M-H]-
Safety Information
2
22
44
DD6497500
P201, P202, P264, P270, P281, P301+P312, P308+P313, P330, P405, P501
H302
|Warning|H302 (14.29%): Harmful if swallowed [Warning Acute toxicity, oral]|P201, P202, P264, P270, P281, P301+P312, P308+P313, P330, P405, and P501|Aggregated GHS information provided by 19 companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)
flubendazole
Flubendazole Use and Manufacturing
(2) when an R contains one or more R1, R2, or R4 substituents, the total number of substituents on that R is not more than 3; or a physiologically acceptable salt thereof; as well as a second active agent, which is a compound selected from the group consisting of albendazole, fenbendazole, flubendazole, mebendazole, oxfendazole, oxibendazole, thiabendazole, levamisole, morantel, ...General procedure: To a stirred mixture of each bendazole in base/solvent (100mM) were added 10 equiv of alcohols indicated in Scheme 1. The reaction proceeded at 90, 100, or 110C for 3h to o/n. For compounds 5 and 7, the reaction mixture was exposed to microwave irradiation for 5-15minat 60 or 70C. Workup: Once the reaction was complete, the solvent was removed under reduced pressure, diluted with four times the reaction volume of EtOAc and washed with water and brine. The organic layer was dried with Na2SO4 and concentrated in vacuo, followed by purification performed on automated flash chromatography system with the desired method commented below.The mixture of General procedure: To a stirred mixture of each bendazole in base/solvent (100mM) were added 10 equiv of alcohols indicated in Scheme 1. The reaction proceeded at 90, 100, or 110C for 3h to o/n. For compounds 5 and 7, the reaction mixture was exposed to microwave irradiation for 5-15minat 60 or 70C. Workup: Once the reaction was complete, the solvent was removed under reduced pressure, diluted with four times the reaction volume of EtOAc and washed with water and brine. The organic layer was dried with Na2SO4 and concentrated in vacuo, followed by purification performed on automated flash chromatography system with the desired method commented below.General procedure: Complex 1 was prepared by suspend one mmol of FLU(313 mg) in 20 ml hot methanol and then mixed with a hotaqueous solution (60 C) of Na2PdCl4 (1 mmol, 294.2 mg), whereupon the complex was precipitated. Complexes 2-4were synthesized by mixing aqueous solution containingone mmol of Na2PdX4 (X = Br, NO3 or SCN), which wereprepared by adding 1 mmol of Na2PdCl4 to NaX or NH4X(4 mmol), with one mmol of suspended FLU in methanol.The resulting mixtures were refluxed for about 6 h, whereuponthe complexes were precipitated. The low molar conductancevalues (9.21-46.10) indicate the non-electrolyticnature of the investigated complexes. The purity of theinvestigated compounds has been checked by thin-layerchromatography as a secondary determinant of purity.General procedure: Complex 1 was prepared by suspend one mmol of FLU(313 mg) in 20 ml hot methanol and then mixed with a hotaqueous solution (60 C) of Na2PdCl4 (1 mmol, 294.2 mg), whereupon the complex was precipitated. Complexes 2-4were synthesized by mixing aqueous solution containingone mmol of Na2PdX4 (X = Br, NO3 or SCN), which wereprepared by adding 1 mmol of Na2PdCl4 to NaX or NH4X(4 mmol), with one mmol of suspended FLU in methanol.The resulting mixtures were refluxed for about 6 h, whereuponthe complexes were precipitated. The low molar conductancevalues (9.21-46.10) indicate the non-electrolyticnature of the investigated complexes. The purity of theinvestigated compounds has been checked by thin-layerchromatography as a secondary determinant of purity.General procedure: Complex 1 was prepared by suspend one mmol of FLU(313 mg) in 20 ml hot methanol and then mixed with a hotaqueous solution (60 C) of Na2PdCl4 (1 mmol, 294.2 mg), whereupon the complex was precipitated. Complexes 2-4were synthesized by mixing aqueous solution containingone mmol of Na2PdX4 (X = Br, NO3 or SCN), which wereprepared by adding 1 mmol of Na2PdCl4 to NaX or NH4X(4 mmol), with one mmol of suspended FLU in methanol.The resulting mixtures were refluxed for about 6 h, whereuponthe complexes were precipitated. The low molar conductancevalues (9.21-46.10) indicate the non-electrolyticnature of the investigated complexes. The purity of theinvestigated compounds has been checked by thin-layerchromatography as a secondary determinant of purity.General procedure: Complex 1 was prepared by suspend one mmol of FLU(313 mg) in 20 ml hot methanol and then mixed with a hotaqueous solution (60 C) of Na2PdCl4 (1 mmol, 294.2 mg), whereupon the complex was precipitated. Complexes 2-4were synthesized by mixing aqueous solution containingone mmol of Na2PdX4 (X = Br, NO3 or SCN), which wereprepared by adding 1 mmol of Na2PdCl4 to NaX or NH4X(4 mmol), with one mmol of suspended FLU in methanol.The resulting mixtures were refluxed for about 6 h, whereuponthe complexes were precipitated. The low molar conductancevalues (9.21-46.10) indicate the non-electrolyticnature of the investigated complexes. The purity of theinvestigated compounds has been checked by thin-layerchromatography as a secondary determinant of purity.
An insectocidal agent.
Veterinary Drug -> ANTHELMINTHIC_AGENT; -> JECFA Functional Classes|Pharmaceuticals -> Animal Drugs -> Approved in Taiwan
Veterinary Drug -> ANTHELMINTHIC_AGENT;
Computed Properties
Molecular Weight:313.28
XLogP3:2.9
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:4
Exact Mass:313.08626942
Monoisotopic Mass:313.08626942
Topological Polar Surface Area:84.1
Heavy Atom Count:23
Complexity:454
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of Flubendazole
-
CN
3 YRS
Business licensedTrader Supplier of api,Intermediates,Organic Chemistry,Inorganic Chemistry,Daily Chemicals,Cosmetic Raw Materals,CATALYST AND AUXILIARY,FLAVORS AND FRAGRANCES,Chemical Pesticides,ADDITIVE -
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
CN
5 YRS
Business licensedTrader Supplier of Peptides,Chemicals,API,AdditivesInquiryCAS No.: 31430-15-6Grade: Pharmaceutical GradeContent: 99% -
CN
2 YRS
Business licensedTrader Supplier of Propylene glycolInquiryCAS No.: 31430-15-6Grade: Food GradeContent: 99% -
CN
6 YRS
Business licensed Certified factoryManufactory Supplier of Drospirenone,Tretinoin,Tranexamic acid,Tretinoin,Desogestrel,Diosmin,Isotretinoin,Ambroxol hcl,Brimonidine Tartrate,Bromhexine hcl,Isotretinoin,Dydrogesterone,Sulfacetamide sodium,Minoxidil,Pentosan Polysulfate Sodium,Tosyl chloride,4-Nitrobenzaldehyde,Bakuchiol,D-Chiro Inositol
Learn More Other Chemicals
-
Flubendazole D3
1173021-08-3
-
Praziquantel
55268-74-1
-
Moxidectin
113507-06-5
-
1-(4-Aminophenyl)-2,3-dihydro-1,3,3-trimethyl-1H-inden-5-amine Formula
54628-89-6
-
Monensin Formula
17090-79-8
-
Pyridinium, 1-ethyl-2,6-bis[2-[4-(1-pyrrolidinyl)phenyl]ethenyl]-, iodide (1:1) Formula
3784-99-4
-
Hydroxystilbamidine Structure
495-99-8
-
Sodium stibogluconate Structure
16037-91-5
-
What is Oxamniquine
21738-42-1
-
What is Furodazole
56119-96-1